• Mashup Score: 1

    People with breast cancer are at increased risk of cardiovascular disease, myocardial injury, and heart failure (HF) due to underlying risk factors, a proinflammatory milieu, and cancer therapy–related cardiovascular toxic effects (CTR-CVT).1 Of the therapies for breast cancer, human epidermal…

    Tweet Tweets with this article
    • Predicting Risk of #Cardiotoxic Effects in Breast Cancer: Are We There Yet? The answer is ‘not yet’. Thoughtful editorial led by ⁦@TaubenA⁩, who I’m so proud of! ⁦@LibinInstitute⁩ ⁦@mmamas1973⁩ https://t.co/XBMxrUP2NK

  • Mashup Score: 7

    Older women with overweight who received cardiotoxic treatment for breast cancer saw a 15% relative CVD risk reduction after following an 8-week time-restricted eating plan, according to research published in JACC: CardioOncology.In a single-arm, feasibility study, researchers also found that older breast cancer survivors who followed a time-restricted eating plan reduced caloric intake without

    Tweet Tweets with this article
    • Older women with overweight who received #cardiotoxic treatment for #breastcancer saw a 15% relative CVD risk reduction after following an 8-week time-restricted eating plan @amyakirkham @UofTKPE @ACCinTouch @HemOncToday #CardioTwitter #CardioOncology https://t.co/0dF4vrZiqP

  • Mashup Score: 0

    Women who developed HF following cardiotoxic breast cancer treatment had fewer comorbidities and better overall 5-year prognosis compared with women who developed HF for other reasons, researchers reported. “Anthracycline- and trastuzumab-based chemotherapy are cardiotoxic, contributing to an increased risk of HF in early-stage breast cancer survivors,” Husam Abdel-Qadir, MD, PhD,

    Tweet Tweets with this article
    • Women who developed HF following #cardiotoxic #BreastCancer treatment had fewer comorbidities and better overall 5-year prognosis compared with women who developed #HeartFailure for other reasons @husam247 @WCHospital @HemOncToday #CardioTwitter https://t.co/QpojaVDhzq